Buscar
Nutriband Inc
NTRBAñadir a la lista de seguimiento
3.090USD
-0.100-3.13%
Cierre 07/01, 16:00（ET）Cotizaciones retrasadas 15 min
37.56MCap. mercado
PérdidaP/E TTM
Más Datos de Nutriband Inc Compañía
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
Información de Nutriband Inc
Símbolo de cotizaciónNTRB
Nombre de la empresaNutriband Inc
Fecha de salida a bolsaJun 20, 2017
Director ejecutivoMelnik (Serguei)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 20
Dirección121 S Orange Ave Ste 1500
CiudadORLANDO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal32801-3241
Teléfono14073776695
Sitio Webhttps://nutriband.com/
Símbolo de cotizaciónNTRB
Fecha de salida a bolsaJun 20, 2017
Director ejecutivoMelnik (Serguei)
Ejecutivos de Nutriband Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Serguei Melnik
Mr. Serguei Melnik
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
839.00K
-11.97%
Mr. Gerald Goodman
Mr. Gerald Goodman
Chief Financial Officer
Chief Financial Officer
86.33K
--
Dr. Jeff Patrick, Pharm.D.
Dr. Jeff Patrick, Pharm.D.
Chief Scientific Officer
Chief Scientific Officer
36.61K
--
Mr. Radu Bujoreanu
Mr. Radu Bujoreanu
Independent Director
Independent Director
15.75K
--
Mr. Mark Hamilton
Mr. Mark Hamilton
Independent Director
Independent Director
13.96K
--
Ms. Irina Gram
Ms. Irina Gram
Independent Director
Independent Director
1.17K
--
Dr. Alan Smith, Ph.D.
Dr. Alan Smith, Ph.D.
Chief Operating Officer, President of 4P Therapeutics
Chief Operating Officer, President of 4P Therapeutics
--
--
Prof. Dr. Stefani C. Mancas
Prof. Dr. Stefani C. Mancas
Independent Director
Independent Director
--
--
Mr. Sergei Glinka
Mr. Sergei Glinka
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Serguei Melnik
Mr. Serguei Melnik
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
839.00K
-11.97%
Mr. Gerald Goodman
Mr. Gerald Goodman
Chief Financial Officer
Chief Financial Officer
86.33K
--
Dr. Jeff Patrick, Pharm.D.
Dr. Jeff Patrick, Pharm.D.
Chief Scientific Officer
Chief Scientific Officer
36.61K
--
Mr. Radu Bujoreanu
Mr. Radu Bujoreanu
Independent Director
Independent Director
15.75K
--
Mr. Mark Hamilton
Mr. Mark Hamilton
Independent Director
Independent Director
13.96K
--
Ms. Irina Gram
Ms. Irina Gram
Independent Director
Independent Director
1.17K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Nutriband Inc?
Los cinco principales accionistas de Nutriband Inc son: Mr. Serguei Melnik
¿Cuántas instituciones poseen acciones de Nutriband Inc (NTRB)?
A fecha de 2026Q1, 45 instituciones poseen acciones de Nutriband Inc, con un valor de mercado combinado de aproximadamente 579.57K, lo que representa el 4.77% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 106153.00.